Guangdong Taienkang Pharmaceutical Co., Ltd. (hereinafter referred to as "Taienkang") was founded in 1999 and is a new OTC market listed company (stock code: 301263). At present, the company has 6 wholly-owned subsidiaries and 2 holding subsidiaries. It has set up operation outlets in 28 provincial regions across the country, forming a sales channel network and sales team covering thousands of hospitals and about 70,000 pharmacies.

Committed to be the leader of China’s health industry.

The main business of the company is to act as an agent for domestic and foreign characteristics and competitive medical products, medical devices, and research, development, production and sales of proprietary Chinese patent medicines, external medicines, medical devices, and health materials and other products.